In Response to Arcidiacono et al: “Should dose intensification be discontinued or should accelerated schemes remain an important area of clinical research?”

Saskia A. Cooke; Jan Jakob Sonke; José S.A. Belderbos; Dirk de Ruysscher

doi:10.1016/j.radonc.2023.109690

In Response to Arcidiacono et al: “Should dose intensification be discontinued or should accelerated schemes remain an important area of clinical research?”

Saskia A. Cooke^*, Jan Jakob Sonke, José S.A. Belderbos, Dirk de Ruysscher

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Article number	109690
Number of pages	2
Journal	Radiotherapy and Oncology
Volume	185
Issue number	1
DOIs	https://doi.org/10.1016/j.radonc.2023.109690
Publication status	Published - 1 Aug 2023

Access to Document

10.1016/j.radonc.2023.109690

Cite this

@article{6cbe9963eced4b35aa185a9cf01144a8,

title = "In Response to Arcidiacono et al: “Should dose intensification be discontinued or should accelerated schemes remain an important area of clinical research?”",

author = "Cooke, {Saskia A.} and Sonke, {Jan Jakob} and Belderbos, {Jos{\'e} S.A.} and {de Ruysscher}, Dirk",

year = "2023",

month = aug,

day = "1",

doi = "10.1016/j.radonc.2023.109690",

language = "English",

volume = "185",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

In Response to Arcidiacono et al: “Should dose intensification be discontinued or should accelerated schemes remain an important area of clinical research?”. / Cooke, Saskia A.; Sonke, Jan Jakob; Belderbos, José S.A. et al.
In: Radiotherapy and Oncology, Vol. 185, No. 1, 109690, 01.08.2023.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - In Response to Arcidiacono et al

T2 - “Should dose intensification be discontinued or should accelerated schemes remain an important area of clinical research?”

AU - Cooke, Saskia A.

AU - Sonke, Jan Jakob

AU - Belderbos, José S.A.

AU - de Ruysscher, Dirk

PY - 2023/8/1

Y1 - 2023/8/1

U2 - 10.1016/j.radonc.2023.109690

DO - 10.1016/j.radonc.2023.109690

M3 - Comment/Letter to the editor

C2 - 37164108

SN - 0167-8140

VL - 185

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

IS - 1

M1 - 109690

ER -